Last reviewed · How we verify
NCT06912438
Emotional Release After Trigger Point Needling to Treat Myofascial Pain of the Head and Neck - Prospective Study
trial testing Fill out questionnaire in Temporomandibular Disorders (TMD) in 100 participants. Enrolling by invitation.
13 March 2027
Quick facts
| Lead sponsor | Tel-Aviv Sourasky Medical Center |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 13 March 2025 |
| Primary completion | 13 March 2027 |
| Estimated completion | 13 March 2027 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Fill out questionnaire
Conditions studied
- Temporomandibular Disorders (TMD) — all drugs for Temporomandibular Disorders (TMD) →
- Temporomandibular Dysfunction (TMD) — all drugs for Temporomandibular Dysfunction (TMD) →
- Temporomandibular Joint and Muscle Disorder — all drugs for Temporomandibular Joint and Muscle Disorder →
Sponsor
Tel-Aviv Sourasky Medical Center
Who can join
18 and older, any sex, with Temporomandibular Disorders (TMD) or Temporomandibular Dysfunction (TMD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Temporomandibular Dysfunction (TMD) as classified by the DC-TMD has a significant psychosocial component referred to as "Axis II". One of the methods of treatment for myofascial TMD is "needing" which could be "dry needling" using only a needle or "wet needling" using local anesthetics. Practitioners of needling commonly observe an emotional release by the patient undergoing needling. This study aims to record and measure the emotional state of patients just before and just after needling for myofascial TMD via questionnaires.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06912438
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Temporomandibular Disorders (TMD)
Currently open trials in the same condition.
- NCT07474662 — Comparing the Effectiveness of Online vs. Face-to-face Physiotherapy for Treating Temporomandibular Disorders · NA · recruiting
- NCT07445516 — Occlusal Equilibration vs. Sham Therapies for TMDs: Post-Trial Follow-up (OEST) · recruiting
- NCT07373184 — Virtual Planning of Total Temporomandibular Joint Replacement · recruiting
- NCT06932406 — Orofacial Pain Self-management: Personality Moderation Effect · NA · recruiting
- NCT07075276 — Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement · NA · recruiting
Other Tel-Aviv Sourasky Medical Center trials
Trials by the same sponsor.
- NCT07380737 — Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot · NA · recruiting
- NCT07104136 — Improving Adherence to COPD Treatments in Primary Care · NA · enrolling by invitation
- NCT07327021 — MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC · Phase 2 · recruiting
- NCT07191249 — A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previousl · Phase 2 · not yet recruiting
- NCT07235332 — Assessing Toxic Metal Exposure From Vegetarian/Vegan, Omnivorous, and Low-carb Diets in Israel. · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06912438 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tel-Aviv Sourasky Medical Center
- Last refreshed: 4 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06912438.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing